1. Konstantopoulos K, Lauren L, Hast R, Reizenstein P (1989) Survival, hospitalization and cause of death in 99 patients with the myelodysplastic syndrome. Anticancer Res 9:893–896
2. Finch SC (2004) Myelodysplasia and radiation. Radiat Res 161:603–606
3. Levine EG, Bloomfield CD (1992) Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure. Semin Oncol 19:47–84
4. Belli C, Acevedo S, Bengio R, Arrossagaray G, Watman N, Rossi N, Garcia J, Flores G, Goldztein S, Larripa I (2002) Detection of risk groups in myelodysplastic syndromes. A multicenter study. Haematologica 87:9–16
5. Germing U, Strupp C, Kuendgen A, Isa S, Knipp S, Hildebrandt B, Giagounidis A, Aul C, Gattermann N, Haas R (2006) Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes. Haematologica 91:1596–1604